Etopophos Side Effects

Generic name: etoposide

Medically reviewed by Drugs.com. Last updated on Apr 21, 2024.

Note: This document provides detailed information about Etopophos Side Effects associated with etoposide. Some dosage forms listed on this page may not apply specifically to the brand name Etopophos.

Applies to etoposide: oral capsule liquid filled.

Other dosage forms:

• intravenous powder for solution, intravenous solution

Important warnings This medicine can cause some serious health issues

Oral route (capsule, liquid filled)

Severe myelosuppression with resulting infection or bleeding may occur with etoposide.

Serious side effects of Etopophos

Along with its needed effects, etoposide (the active ingredient contained in Etopophos) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking etoposide:

More common side effects

• black, tarry stools
• bleeding gums
• blood in the urine or stools
• chest pain
• chills
• cough
• fever
• painful or difficult urination
• pale skin
• pinpoint red spots on the skin
• shortness of breath
• sore throat
• sores, ulcers, or white spots on the lips or in the mouth
• swollen glands
• troubled breathing with exertion
• unusual bleeding or bruising
• unusual tiredness or weakness

Less common side effects

• blurred vision
• confusion
• cough
• difficulty with swallowing
• dizziness
• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
• fast heartbeat
• feeling of warmth
• headache
• hives
• itching
• nervousness
• numbness or tingling in the fingers or toes
• pounding in the ears
• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
• redness of the face, neck, arms, and occasionally, upper chest
• skin rash
• slow or fast heartbeat
• sweating
• tightness in the chest
• wheezing

Rare side effects

• bone pain

Incidence not known

• abdominal or stomach pain, severe
• blistering, peeling, or loosening of the skin
• cough or hoarseness
• dark urine
• diarrhea
• difficult breathing
• drowsiness
• joint or muscle pain
• loss of appetite
• lower back or side pain
• muscle tremors
• nausea or vomiting
• rapid, deep breathing
• red, irritated eyes
• red skin lesions, often with a purple center
• restlessness
• seizures
• stomach cramps
• yellow eyes or skin

Other side effects of Etopophos

Some side effects of etoposide may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

• hair loss or thinning of the hair
• swelling or inflammation of the mouth
• weight loss

Incidence not known

• bad, unusual, or unpleasant (after) taste
• change in taste
• constipation
• cracked lips
• general feeling of discomfort or illness
• heartburn
• lack or loss of strength
• pain or burning in the throat
• sleepiness or unusual drowsiness

For healthcare professionals

Applies to etoposide: intravenous powder for injection, intravenous solution, oral capsule.

Hematologic adverse events

• Very common (10% or more): Myelosuppression (sometimes fatal), leukopenia, thrombocytopenia, neutropenia, anemia^[Ref]

Gastrointestinal

• Very common (10% or more): Abdominal pain, constipation, nausea, vomiting, anorexia, mucositis (including stomatitis and esophagitis)
• Common (1% to 10%): Diarrhea
• Rare (less than 0.1%): Dysphagia, dysgeusia^[Ref]

Cardiovascular

• Common (1% to 10%): Myocardial infarction, arrhythmia, transient systolic hypotension (following rapid IV administration), hypertension
• Uncommon (0.1% to 1%): Cyanosis
• Rare (less than 0.1%): Heart failure^[Ref]

Hypersensitivity

• Common (1% to 10%): Anaphylaxis (sometimes fatal)^[Ref]

Dermatologic

• Very common (10% or more): Alopecia, pigmentation
• Common (1% to 10%): Rash, urticaria, pruritus
• Rare (less than 0.1%): Stevens-Johnson syndrome, toxic epidermal necrolysis, radiation recall dermatitis, maculopapular rash^[Ref]

Hepatic

• Common (1% to 10%): Hepatotoxicity^[Ref]

Other

• Very common (10% or more): Asthenia, malaise
• Frequency not reported: Fever^[Ref]

Respiratory

• Rare (less than 0.1%): Pulmonary fibrosis, interstitial pneumonitis, bronchospasm, dyspnea^[Ref]

Immunologic

• Frequency not reported: Infectious complications^[Ref]

Metabolic

• Frequency not reported: Tumor lysis syndrome (sometimes fatal) has been reported following the use of this drug in association with other chemotherapeutic drugs^[Ref]

Nervous system

• Common (1% to 10%): Dizziness
• Uncommon (0.1% to 1%): Peripheral neuropathy
• Rare (less than 0.1%): Seizure (occasionally associated with allergic reactions), optic neuritis, cortical blindness transient, neurotoxicity (e.g., somnolence, fatigue)
• Frequency not reported: Aftertaste^[Ref]

Very common (10% or more: Neurotoxicity (e.g., somnolence, fatigue)

Ocular

• Rare (0.01% to 0.1%): Optic neuritis, transient cortical blindness^[Ref]

Local

• Common (1% to 10%): Extravasation (e.g., local soft tissue toxicity, swelling, pain, cellulitis, necrosis including skin necrosis), phlebitis

Oncologic

• Common (1% to 10%): Acute leukemia
• Frequency not reported: Acute promyelocytic leukemia^[Ref]

Further information

Etopophos side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer